Merck & Co Inc

NYSE: MRK
$98.70
+$0.12 (+0.1%)
Real Time Data Delayed 15 Min.

MRK Articles

The April 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also help generate billions for drug manufacturers. Pharmaceutical...
Apple continues to be the American company with most money parked offshore. The amount has reached $181 billion.
April 14, 2016: Markets opened slightly higher Thursday following rather cool data on the consumer price index and fewer new claims for unemployment benefits than expected. Equities spent most of the...
The March 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
April 6, 2016: Markets opened higher on Wednesday following mixed trading in Asia. The dollar weakened and the release of the minutes from the FOMC’s March meeting gave equities an additional boost...
Ionis Pharmaceuticals led biotech stocks early on Wednesday following a key patent dispute win in the U.S. court system.
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest decreased.
The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
The top analyst upgrades, downgrades and initiations seen on Tuesday include Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce,com, Tesla and Yelp.
If you ever want to look for value in a sector in the stock market, then when you see Congress calling in some of the top companies to scold them for political purposes, you may want to start buying.
After Pfizer and Merck released their most recent earnings reports last week, analysts weighed in on both of these pharmaceutical giants.
Merck reported mixed fourth-quarter financial results before the markets opened Wednesday.